IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy
Christian S. Hinrichs(National Institutes of Health), Nicholas P. Restifo(National Cancer Institute)
Cited by 459
Related Papers
Identification of essential genes for cancer immunotherapy
|Nature|2017|890
Increased intensity lymphodepletion and adoptive immunotherapy—how far can we go?
|Nature Clinical Practice Oncology|2006|348
BACH2 regulates CD8+ T cell differentiation by controlling access of AP-1 factors to enhancers
|Nature Immunology|2016|329
T-Cell Receptor Gene Therapy for Human Papillomavirus–Associated Epithelial Cancers: A First-in-Human, Phase I/II Study
|Journal of Clinical Oncology|2019|259